Trial intelligence / Profile preview

Amnion Chorion Membrane vs SCTG for Gingival Recession

NCT02656732Completed

Sponsor
Cairo University
Start
Jun 2014
Primary completion
Apr 2015
Modality
Implantable Devices, Tissue Cells
01

Overview

Randomised trial of BioXclude in gingival recession (2 arms), sponsored by Cairo University. Primary endpoint: Recession Depth at 6 months. Started Jun 2014; status: completed.

02

Drugs

BioXclude
03

Conditions

gingival recession

Beyond the preview

Go deeper on NCT02656732.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02656732.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call